Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray co

Details Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray co Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray co

1995-08-22

1997-07-01

Hollinden, Gary E.

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

X-ray contrast imaging agent

424 9451, 560 41, 562449, 562887, 558276, A61K 4904, C07C27102, C07C 6996, C07C 6368

Patent

active

056435525

ABSTRACT:
This invention relates to methods of x-ray diagnostic imaging the blood pool, liver, spleen, and/or lymph system of a mammal comprising administering a contrast effective amount of a mixed carbonic anhydride as a contrast agent having the structure ##STR1## X is H, NR.sup.1 R.sup.2 or CONR.sup.1 R.sup.3, R.sup.1 is H or alkyl

REFERENCES:
patent: 3097228 (1963-07-01), Larsen
patent: 5322679 (1994-06-01), Bacon et al.
patent: 5472683 (1995-12-01), Illig
patent: 5573749 (1996-11-01), Illig
Swanson et al, "Pharmaceuticals in Medical Imaging", 1990, MacMillan Publishing Company.

Affiliated with

Also associated with

Rating

Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray co will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-594576